Expanding Options, New Questions in Early Relapsed or Refractory Multiple Myeloma Care
Multiple myeloma is entering an era of unprecedented therapeutic choice—and equally unprecedented uncertainty. A new clinical perspective by C.R. Tan ...
Tag: Multiple Myeloma
Mayo Clinic study finds no survival benefit from longer multiple myeloma maintenance therapy
Rochester, Minn. — A major U.S.-led cooperative group clinical trial coordinated by Mayo Clinic researchers has found that extending maintenance ...
ECOG-ACRIN ENDURANCE Trial Publishes Randomized Evidence on Lenalidomide Maintenance Duration in Multiple Myeloma
A landmark phase 3 trial in newly diagnosed multiple myeloma challenges a long-standing standard: indefinite lenalidomide maintenance. For patients who ...
Exploring How Pomalidomide Enhances Immune Response in the Battle Against Multiple Myeloma
Pomalidomide (POM) has emerged as a pivotal agent in the treatment landscape for multiple myeloma, a malignancy that significantly compromises ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!